You are here
May 11, 2020
Dr. Collins coauthors a Science perspective stressing the importance of a coordinated strategy to accelerate multiple COVID-19 vaccine candidates
Drs. Corey, Mascola, Fauci and Collins explain why a collaborative approach to developing COVID-19 vaccines is essential, and how the ACTIV public-private partnership spearheaded by NIH aims to facilitate such collaboration among governments, academic institutions, industry, and global philanthropic partners. Science. Online: May 11, 2020.
This page last reviewed on May 11, 2020